Cargando…
Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study
BACKGROUND AND OBJECTIVES: Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standard doses. METHODS: We studied electronic health records from...
Autores principales: | Andersen, Kathleen M., Joseph, Corey S., Mehta, Hemalkumar B., Streiff, Michael B., Betz, Joshua F., Bollinger, Robert C., Fisher, Arielle M., Gupta, Amita, LeMaistre, Charles F., Robinson, Matthew L., Xu, Yanxun, Ng, Derek K., Alexander, G. Caleb, Garibaldi, Brian T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287673/ https://www.ncbi.nlm.nih.gov/pubmed/35859579 http://dx.doi.org/10.1002/rth2.12753 |
Ejemplares similares
-
THE EMERGENCE OF PSEUDOTUBERCULOSIS IN RATS GIVEN CORTISONE
por: LeMaistre, Charles, et al.
Publicado: (1952) -
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
por: Garibaldi, Brian T., et al.
Publicado: (2021) -
Custom astrocyte-mediated vasomotor responses to neuronal energy demand
por: LeMaistre, Jillian L, et al.
Publicado: (2009) -
Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020) -
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative
por: Andersen, Kathleen M, et al.
Publicado: (2022)